SCHEMBL13633807

SCHEMBL13633807

Cc1ccc2c(=O)n(-c3ccc(NC(=O)NS(=O)(=O)c4ccc(Cl)s4)cn3)c(=O)[nH]c2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY12 Q9H244 5/20 0.58
FBP1 P09467 2/20 0.42
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
HTT P42858 3/20 0.38
LMNA P02545 1/20 0.38
RECQL P46063 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA4 P22748 1/20 0.36
CA6 P23280 1/20 0.36
CA5A P35218 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA13 Q8N1Q1 1/20 0.36
CA14 Q9ULX7 1/20 0.36
USP2 O75604 1/20 0.36
KIT P10721 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9922330 0.92 P2RY12 (0.62) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL9922321 0.92 P2RY12 (0.57) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL9922101 0.90 P2RY12 (0.56) P2RY12FBP1KMT2AMEN1LMNA
SCHEMBL9922322 0.90 P2RY12 (0.56) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL9922092 0.90 P2RY12 (0.56) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL9923145 0.88 P2RY12 (0.56) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL1548643 0.88 P2RY12 (0.55) P2RY12FBP1KMT2AMEN1HTT
SCHEMBL9922859 0.88 P2RY12 (0.55) P2RY12FBP1KMT2AMEN1KIT
SCHEMBL9922093 0.87 P2RY12 (0.53) P2RY12FBP1KMT2AHTTSMN1; SMN2
SCHEMBL9922672 0.87 P2RY12 (0.56) P2RY12FBP1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622474-B2 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis PORTOLA PHARMACEUTICALS, INC. (US) 2009-11-24 US disclosed